Drug
Testosterone 17 beta-cypionate clinical trials
Also written Testosterone cypionate and Depo-Testosterone.
Keep track of what changes. Save the testosterone 17 beta-cypionate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Other names
Studies by the year they started
26 studies that test it; most in 2026 (5); 1 more planned to start later
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 26
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (4) · Brigham and Women's Hospital (2) · University of Miami (2) · VA Office of Research and Development (2) · University of California, San Diego (2) · Roswell Park Cancer Institute (1) · Emory University (1) · Leticia Maria Defendi Barboza Marson (1)
Often tested with
Tested in the same studies.
Testosterone (3) · Leuprolide (2) · Darolutamide (2) · Anastrozole (2) · Testosterone enanthate (2) · Bupropion (1) · Danazol (1) · Chlorthalidone (1)
Studies
Open first, then newest update. How each study uses testosterone 17 beta-cypionate is read from its arms, and is right about nine times in ten.
Testing it · 27
- Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI TrialNot yet recruitingPhase 2/3VA Office of Research and DevelopmentNCT07742553Written as testosterone cypionate
- Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active SurveillanceNot yet recruitingPhase 4University of MiamiNCT07278362Written as Testosterone cypionate
- Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPCRecruitingPhase 2H. Lee Moffitt Cancer Center and Research InstituteNCT07476001Written as Testosterone cypionate (Tc)
- Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesEnrolling by invitationNot applicableEnhanced Emirates LimitedNCT07568574Written as Testosterone Cypionate
- Supraphysiologic Testosterone Priming Induces Darolutamide Extended ResponseRecruitingPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT07142551Written as Testosterone cypionate
- Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal MenNot yet recruitingPhase 4Azurity PharmaceuticalsNCT07328542Written as Testosterone Cypionate Injection 200 mg/mL
- Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)CompletedPhase 2Latin American Cooperative Oncology GroupNCT04558866Written as Testosterone Cypionate
- Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate CancerActive, not recruitingPhase 1Roswell Park Cancer InstituteNCT06305598Written as Testosterone Cypionate
- Improving Quality of Life of Prostate Cancer Survivors With Androgen DeficiencyCompletedPhase 2Dana-Farber Cancer InstituteNCT03716739Written as Testosterone Cypionate 100 MG/ML
- The Anabolic Effect of Testosterone on Pelvic Floor MusclesActive, not recruitingPhase 2Brigham and Women's HospitalNCT06111209Written as Testosterone cypionate
- Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low TestosteroneActive, not recruitingPhase 1Emory UniversityNCT04731376Written as Testosterone Cypionate
- Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial)CompletedPhase 2Brigham and Women's HospitalNCT04895306Written as Testosterone Cypionate
- Androgen Effects on the Reproductive Neuroendocrine AxisTerminatedPhase 4University of California, San DiegoNCT06450405Written as Testosterone Cypionate 50 MG/ML Injectable Solution
- Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men with ErythrocytosisCompletedNot applicableUniversity of Sao PauloNCT05487794Written as Testosterone Cypionate 100 MG/ML
- Hormone Secretion in Transgender MalesWithdrawnPhase 4University of California, San DiegoNCT04321551Written as Testosterone Cyp 200Mg/Ml Inj (in Oil)
- TESTO-TRIAL: Use of Testosterone in Critically Ill PatientsActive, not recruitingPhase 4Leticia Maria Defendi Barboza MarsonNCT06592144Written as Testosterone cypionate (200mg/3ml)
- Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate CancerTerminatedPhase 1Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT02995330Written as testosterone cypionate
- A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone InjectionsCompletedPhase 4University of MiamiNCT04439799Written as Testosterone Cypionate 200 Mg/ML
- Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen TherapyCompletedPhase 2Hospital Sirio-LibanesNCT04424654Written as Testosterone cypionate
- Can Testosterone Accelerate Injury Recovery After Arthroscopic Rotator Cuff RepairWithdrawnPhase 2/3Orthopedic Institute, Sioux Falls, SDNCT04345666Written as Testosterone cypionate
See all 27 studies that test testosterone 17 beta-cypionate →
Given in every arm · 9 — testosterone 17 beta-cypionate is usual care beside what is tested
- Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate CancerNot yet recruitingPhase 2/3ECOG-ACRIN Cancer Research GroupNCT07852195Written as Testosterone Cypionate
- Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPCRecruitingPhase 2Yale UniversityNCT06100705Written as Testosterone Cypionate
- Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA StudyRecruitingPhase 2University of WashingtonNCT06039371Written as Testosterone Cypionate
- Sequential Testosterone and Enzalutamide Prevents Unfavorable ProgressionRecruitingPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT04363164Written as Testosterone cypionate
- The COSMYC Trial (COmbined Suppression of MYC)RecruitingPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT06922318Written as Testosterone cypionate
- Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate CancerRecruitingPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT06059118Written as testosterone cypionate
- Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate CancerCompletedPhase 2University of WashingtonNCT03516812Written as Testosterone Cypionate
- COMbination of Bipolar Androgen Therapy and NivolumabCompletedPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT03554317Written as Testosterone cypionate
- RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)CompletedPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT02090114Written as Testosterone cypionate
Codes
What other systems call testosterone 17 beta-cypionate · ClinicalTrials.gg INT002641
- MeSH (NLM) C016131testosterone 17 beta-cypionateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) M0XW1UBI14TESTOSTERONE CYPIONATEConfirmed FDA, NLM
- RxNorm 835827One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C016131 | testosterone 17 beta-cypionate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | M0XW1UBI14 | TESTOSTERONE CYPIONATE | Confirmed FDA, NLM |
| RxNorm | 835827 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.